Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Artificial Oxygen Carriers-Past, Present, and Future-a Review of the Most Innovative and Clinically Relevant Concepts.

Ferenz KB, Steinbicker AU.

J Pharmacol Exp Ther. 2019 May;369(2):300-310. doi: 10.1124/jpet.118.254664. Epub 2019 Mar 5.

PMID:
30837280
2.

Investigation of albumin-derived perfluorocarbon-based capsules by holographic optical trapping.

Köhler J, Ruschke J, Ferenz KB, Esen C, Kirsch M, Ostendorf A.

Biomed Opt Express. 2018 Jan 23;9(2):743-754. doi: 10.1364/BOE.9.000743. eCollection 2018 Feb 1.

3.

Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart .

Wrobeln A, Schlüter KD, Linders J, Zähres M, Mayer C, Kirsch M, Ferenz KB.

Artif Cells Nanomed Biotechnol. 2017 Jun;45(4):723-730. doi: 10.1080/21691401.2017.1284858. Epub 2017 Feb 8.

PMID:
28278587
4.

Albumin-derived perfluorocarbon-based artificial oxygen carriers: A physico-chemical characterization and first in vivo evaluation of biocompatibility.

Wrobeln A, Laudien J, Groß-Heitfeld C, Linders J, Mayer C, Wilde B, Knoll T, Naglav D, Kirsch M, Ferenz KB.

Eur J Pharm Biopharm. 2017 Jun;115:52-64. doi: 10.1016/j.ejpb.2017.02.015. Epub 2017 Feb 20.

PMID:
28232105
5.

Perfluorodecalin-Filled Poly(n-butyl-cyanoacrylate) Nanocapsules as Potential Artificial Oxygen Carriers: Preclinical Safety and Biocompatibility.

Laudien J, Groß-Heitfeld C, Mayer C, de Groot H, Kirsch M, Ferenz KB.

J Nanosci Nanotechnol. 2015 Aug;15(8):5637-48.

PMID:
26369130
6.

Perfluorodecalin-soluble fluorescent dyes for the monitoring of circulating nanocapsules with intravital fluorescence microscopy.

Laudien J, Naglav D, Groβ-Heitfeld C, Ferenz KB, de Groot H, Mayer C, Schulz S, Schnepf A, Kirsch M.

J Microencapsul. 2014;31(8):738-45. doi: 10.3109/02652048.2014.918668. Epub 2014 Jun 25.

PMID:
24963954
7.

Safety of poly (ethylene glycol)-coated perfluorodecalin-filled poly (lactide-co-glycolide) microcapsules following intravenous administration of high amounts in rats.

Ferenz KB, Waack IN, Laudien J, Mayer C, Broecker-Preuss M, Groot Hd, Kirsch M.

Results Pharma Sci. 2014 Apr 30;4:8-18. doi: 10.1016/j.rinphs.2014.04.001. eCollection 2014.

8.

Artificial oxygen carriers based on perfluorodecalin-filled poly(n-butyl-cyanoacrylate) nanocapsules.

Stephan C, Schlawne C, Grass S, Waack IN, Ferenz KB, Bachmann M, Barnert S, Schubert R, Bastmeyer M, de Groot H, Mayer C.

J Microencapsul. 2014;31(3):284-92. doi: 10.3109/02652048.2013.843600. Epub 2013 Oct 14.

PMID:
24124886
9.

Acid-base and electrolyte status during normovolemic hemodilution with succinylated gelatin or HES-containing volume replacement solutions in rats.

Teloh JK, Ferenz KB, Petrat F, Mayer C, de Groot H.

PLoS One. 2013 Sep 2;8(9):e72848. doi: 10.1371/journal.pone.0072848. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/2881843c-2649-4710-be8f-c7e399cb6660.

10.

Long-circulating poly(ethylene glycol)-coated poly(lactid-co-glycolid) microcapsules as potential carriers for intravenously administered drugs.

Ferenz KB, Waack IN, Mayer C, de Groot H, Kirsch M.

J Microencapsul. 2013;30(7):632-42. doi: 10.3109/02652048.2013.770098. Epub 2013 Mar 14.

PMID:
23489015
11.

Nerve growth factor and brain-derived neurotrophic factor but not granulocyte colony-stimulating factor, nimodipine and dizocilpine, require ATP for neuroprotective activity after oxygen-glucose deprivation of primary neurons.

Ferenz KB, Gast RE, Rose K, Finger IE, Hasche A, Krieglstein J.

Brain Res. 2012 Apr 11;1448:20-6. doi: 10.1016/j.brainres.2012.02.016. Epub 2012 Feb 13.

PMID:
22386494
12.

ATP-NGF-complex, but not NGF, is the neuroprotective ligand.

Ferenz KB, Rose K, König S, Krieglstein J.

Neurochem Int. 2011 Dec;59(7):989-95. doi: 10.1016/j.neuint.2011.08.020. Epub 2011 Sep 10.

PMID:
21930174
13.

Binding of ATP to vascular endothelial growth factor isoform VEGF-A165 is essential for inducing proliferation of human umbilical vein endothelial cells.

Gast RE, König S, Rose K, Ferenz KB, Krieglstein J.

BMC Biochem. 2011 May 27;12:28. doi: 10.1186/1471-2091-12-28.

14.

Interaction of clodronate with fibroblast growth factor 2 reduces FGF2-activity in endothelial cells.

Rose K, Finger IE, Ferenz KB.

Biomed Pharmacother. 2011 Feb;65(1):46-51. doi: 10.1016/j.biopha.2010.10.002. Epub 2010 Nov 4.

PMID:
21177067
15.

Binding of ATP to nerve growth factor: characterization and relevance for bioactivity.

Hasche A, Ferenz KB, Rose K, König S, Humpf HU, Klumpp S, Krieglstein J.

Neurochem Int. 2010 Jan;56(2):276-84. doi: 10.1016/j.neuint.2009.10.012. Epub 2009 Nov 6.

PMID:
19897001

Supplemental Content

Loading ...
Support Center